6505--Levetiracetam Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0001

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This procurement notice announces the award for the supply of Levetiracetam Tablets, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), as part of the Department of Veterans Affairs’ ongoing efforts to ensure the availability of essential pharmaceuticals for its healthcare system. The contract, identified by procurement number 36E79726R0001, is managed by the NAC Pharmaceuticals office (organization key: 500000036), a federal entity within the Department of Veterans Affairs. The primary objective of this procurement is to secure a reliable source of Levetiracetam Tablets, a medication commonly used in the management of epilepsy and seizure disorders. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Levetiracetam Tablets, adhering to all applicable regulatory standards and quality requirements as outlined for pharmaceutical preparation manufacturing. The intended outcome is to maintain an uninterrupted supply chain of this critical medication to support the health and well-being of veterans served by the VA healthcare system. Key requirements for this contract include the consistent production and timely delivery of Levetiracetam Tablets that meet the VA’s stringent quality and safety standards. Contractors are expected to demonstrate robust manufacturing capabilities, compliance with federal pharmaceutical regulations, and the capacity to fulfill the VA’s volume and delivery schedule requirements. The awarded contractor is responsible for ensuring that all deliverables align with the specifications set forth by the Department of Veterans Affairs. This procurement is classified under Product Service Code 6505, which pertains to drugs and biologicals, further emphasizing the specialized nature of the requirement. The notice remains active as of the posting date, November 2, 2026, and is accessible via the official SAM.gov portal (Opportunity ID: 78926691bed0445dbbe5248722361b7b). Interested parties seeking further information or clarification may contact the primary point of contact, Youlanda Duggar, at [email protected] or by phone at 708-786-4943. No specific set-aside requirements or special considerations are indicated in the provided information. Contractors evaluating this opportunity should ensure alignment with the pharmaceutical manufacturing classification and be prepared to meet the VA’s high standards for quality, reliability, and regulatory compliance throughout the contract lifecycle.